GRAIL, Inc. (GRAL)

Healthcare · Diagnostics Research · NASDAQ

GRAIL, Inc. (GRAL) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $3.10B and a free-cash-flow yield of -11.7%. Over the most recent reported fiscal year, revenue grew 17.2%.

Market cap	$3.10B
Trailing P/E	—
FCF yield	-11.7%
Revenue growth (YoY)	+17.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Diagnostics Research

Explore live GRAL data on Nama Insights →